Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1995
[Clinical significance of proliferating cell nuclear antigen (PCNA) and argyrophilic nucleolar organizer region (AgNOR) in testicular tumors]C Ohyama, A Ito, S Tokuyama, et al.Transplantation Proceedings|February 8, 2012
A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipientsS Hatakeyama, T Fujita, T Yoneyama, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 1, 1991
[Evaluation of bone metastases from renal cell carcinoma]S Hoshi, S Orikasa, K Yoshikawa, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|April 1, 1990
[S-phase cells of human bladder tumors by in vivo bromodeoxyuridine labeling]C Ohyama, H Nakazumi, M Satoh, et al.The Journal of Thoracic and Cardiovascular Surgery|September 1, 1987
Reconsiderations of indications for open mitral commissurotomy based on pathologic features of the stenosed mitral valve. A fourteen-year follow-up study in 347 consecutive patientsS Nakano, Y Kawashima, H Hirose, et al.Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|October 1, 1991
[Whole layer needle biopsy for evaluation of neoadjuvant therapy to invasive bladder cancer]S Hoshi, S Orikasa, K Yoshikawa, et al.Urologic Oncology|January 14, 2011
Telomerase activity Simplification of assay and detection in bladder tumor and urinary exfoliated cellsS Hoshi, T Takahashi, M Satoh, et al.The Journal of Urology|August 1, 1991
High energy underwater shock wave treatment on implanted urinary bladder cancer in rabbitsS Hoshi, S Orikasa, M Kuwahara, et al.International Journal of Oncology|May 6, 2011
G(M3) inhibits murine MET-2 tumor invasion and growthC Ohyama, S Kawamura, K Suzuki, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|May 5, 1999
Neoadjuvant therapy and bladder substitute for invasive bladder cancer: 20 years experience at Tohoku UniversityS Hoshi, S Orikasa, K Yoshikawa, et al.Pageof 8